Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Cash from Financing Activities (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Cash from Financing Activities for 4 consecutive years, with -$293.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities rose 77.06% year-over-year to -$293.0 million, compared with a TTM value of $617.0 million through Dec 2025, up 207.68%, and an annual FY2025 reading of $617.0 million, up 207.68% over the prior year.
  • Cash from Financing Activities was -$293.0 million for Q4 2025 at GE HealthCare Technologies, down from -$165.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $1.4 billion in Q2 2025 and bottomed at -$1.3 billion in Q4 2024.
  • Average Cash from Financing Activities over 4 years is -$78.5 million, with a median of -$159.0 million recorded in 2024.
  • The sharpest move saw Cash from Financing Activities plummeted 2332.43% in 2023, then surged 3908.33% in 2024.
  • Year by year, Cash from Financing Activities stood at -$37.0 million in 2022, then tumbled by 2332.43% to -$900.0 million in 2023, then tumbled by 41.89% to -$1.3 billion in 2024, then skyrocketed by 77.06% to -$293.0 million in 2025.
  • Business Quant data shows Cash from Financing Activities for GEHC at -$293.0 million in Q4 2025, -$165.0 million in Q3 2025, and $1.4 billion in Q2 2025.